You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Drug Relapse

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML Trial in Berne (Image-based ex-vivo drug screening platform (pharmacoscopy))

Recruiting
  • AML
  • Image-based ex-vivo drug screening platform (pharmacoscopy)
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Feb 8, 2023

Substance Abuse Disorder Trial in Morgantown (PRSS (Peer Recovery Support Specialist))

Recruiting
  • Substance Abuse Disorder
  • PRSS (Peer Recovery Support Specialist)
  • Morgantown, West Virginia
    West Virginia University Rockefeller Neuroscience Institute
Jul 27, 2023

Patients With Schizophrenia Trial (Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG))

Not yet recruiting
  • Patients With Schizophrenia
  • Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG)
  • (no location specified)
May 1, 2023

TSI and Its Relationship With Graves' Disease Relapse

Completed
  • Graves Disease
  • +2 more
  • TSI
  • Ho Chi Minh City, Vietnam
    Hoa Hao Clinic
Feb 2, 2023

Abilify Prolonged Release Aqueous Suspension for IM Injection

Recruiting
  • Bipolar Disorder I
  • Abilify prolonged release aqueous suspension for IM injection (Aripiprazole)
  • Osaka, Japan
    Pharmacovigilance Department
Jan 23, 2023

Nicotine Dependence Trial in Baltimore (Transcranial Direct Current Stimulation, Sham)

Suspended
  • Nicotine Dependence
  • Transcranial Direct Current Stimulation
  • sham
  • Baltimore, Maryland
    National Institute on Drug Abuse
Jan 4, 2023

Opioid Dependence, Craving Trial in Providence (tDCS, sham tDCS)

Recruiting
  • Opioid Dependence
  • Craving
  • tDCS
  • sham tDCS
  • Providence, Rhode Island
    Butler Hospital
Dec 5, 2022

Opioid Use Trial in Rochester (Wiidookaage'win Facebook Group)

Recruiting
  • Opioid Use
  • Wiidookaage'win Facebook Group
  • Rochester, Minnesota
    Mayo Clinic Rochester
Jan 11, 2023

Postpartum Smoking Relapse Trial in Minneapolis (Bupropion Extended Release Oral Tablet, Placebo oral tablet)

Recruiting
  • Postpartum Smoking Relapse
  • Bupropion Extended Release Oral Tablet
  • Placebo oral tablet
  • Minneapolis, Minnesota
    University of Minnesota
Jul 12, 2022

Methadone or Buprenorphine Detoxoxification Trial in New Haven (MAT taper with galantamine, MAT taper with )

Completed
Has Results
  • Methadone or Buprenorphine Detoxoxification
  • MAT taper with galantamine
  • MAT taper with placebo
  • New Haven, Connecticut
    APT Foundation
Jul 27, 2022

Opioid Use Disorder Trial (Wiidookaage'win Facebook Group)

Not yet recruiting
  • Opioid Use Disorder
  • Wiidookaage'win Facebook Group
  • (no location specified)
Aug 10, 2023

Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

Recruiting
  • Aplastic Anemia
  • +2 more
  • Beijing, China
    Peking union medical college hospital
Aug 20, 2023

Opioid-use Disorder Trial in New York (Buprenorphine/naloxone, Placebo)

Recruiting
  • Opioid-use Disorder
  • New York, New York
    Stars/Nyspi
Aug 11, 2022

Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

Not yet recruiting
  • Multiple Myeloma
  • Allogeneic Stem Cell Transplantation
  • CARTemis-1
  • Santander, Cantabria, Spain
  • +4 more
Aug 1, 2023

Cocaine Use Disorder Trial in Houston (Cognitive Behavioral Therapy (CBT), Pioglitazone, Placebo)

Recruiting
  • Cocaine Use Disorder
  • Cognitive Behavioral Therapy (CBT)
  • +2 more
  • Houston, Texas
    UTHealth Center for Neurobehavioral Research on Addiction
Jun 7, 2022

Copaxone Subcutaneous Injection Syringe Special Drug Use-Result

Recruiting
  • Multiple Sclerosis
  • Glatiramer acetate
  • Tokyo, Japan
    Takeda selected site
Jan 12, 2022

Graves Disease, Relapse, Treatment Trial in Nanjing (Methimazole)

Recruiting
  • Graves Disease
  • +3 more
  • Nanjing, China
    the First Affiliated Hospital of Nanjing Medical University
Jul 21, 2022

Opioid Use Disorder, Chronic Pain Trial (Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP),

Not yet recruiting
  • Opioid Use Disorder
  • Chronic Pain
  • Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP)
  • Enhance Usual Care (EUC)
  • (no location specified)
Oct 5, 2022

Opioid-use Disorder Trial in West Chester (Mindfulness-Based Relapse Prevention - Rolling Admission (MBRP-RA),

Recruiting
  • Opioid-use Disorder
  • Mindfulness-Based Relapse Prevention - Rolling Admission (MBRP-RA)
  • Treatment-As-Usual
  • West Chester, Pennsylvania
    Gaudenzia, Inc. (West Chester House)
Sep 11, 2021

During Early Recovery as a Marker for Relapse

Completed
  • Substance Use Disorder
  • MRI: Brain Imaging Data Collection
  • Minneapolis, Minnesota
    University of Minnesota
Jan 19, 2022

Indian Children With Acute Lymphoblastic Leukemia

Not yet recruiting
  • ALL, Childhood
  • +7 more
    • New Delhi, India
    • +1 more
    Aug 22, 2022

    Smoking Cessation Trial in Nashville (NRT + QuitBuddy, NRT + QuitBuddy-Recall, Treatment as Usual)

    Active, not recruiting
    • Smoking Cessation
    • NRT + QuitBuddy
    • +2 more
    • Nashville, Tennessee
      Meharry Medical College
    Dec 9, 2021

    Hepatitis, Drug-Induced Trial in Denmark (Mycophenolate Mofetil, Tacrolimus, Solu-Medrol)

    Recruiting
    • Hepatitis, Drug-Induced
    • Mycophenolate Mofetil
    • +3 more
    • Herlev, Copenhagen, Denmark
    • +4 more
    Dec 11, 2022

    Autoimmune Diseases Trial in Beijing (Drug free, IS monotherapy and GC combined with IS)

    Recruiting
    • Autoimmune Diseases
    • Drug free, IS monotherapy and GC combined with IS
    • Beijing, Beijing, China
      Beijing Friendship Hospital
    Jan 21, 2022

    Cocaine-Related Disorders Trial in Houston (Acceptance and Commitment Therapy (ACT), Drug Counseling (DC), Contingency

    Completed
    • Cocaine-Related Disorders
    • Acceptance and Commitment Therapy (ACT)
    • +4 more
    • Houston, Texas
      UTHealth Center for Neurobehavioral Research on Addiction
    Oct 13, 2021